Intermittent Catheters Market Size, Share and Growth Forecast 2025-2033
Rohit Pujari
Market Overview:
The Intermittent Catheters Market is experiencing robust expansion, driven by Increasing Prevalence of Urological Disorders, Rising Adoption of Appropriate Reimbursement Rules and Growing Geriatric Population. According to IMARC Group's latest research publication, "Intermittent Catheters Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025–2033", The global intermittent catheters market size reached USD 2.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 4.9 Billion by 2033, exhibiting a growth rate (CAGR) of 5.72% during 2025-2033.
This detailed analysis primarily encompasses industry size, business trends, market share, key growth factors, and regional forecasts. The report offers a comprehensive overview and integrates research findings, market assessments, and data from different sources. It also includes pivotal market dynamics like drivers and challenges, while also highlighting growth opportunities, financial insights, technological improvements, emerging trends, and innovations. Besides this, the report provides regional market evaluation, along with a competitive landscape analysis.
Download a sample PDF of this report: https://www.imarcgroup.com/intermittent-catheters-market/requestsample
Our Report Includes:
- Market Dynamics
- Market Trends and Outlook
- Competitive Analysis
- Industry Segmentation
- Strategic Recommendations
Growth Factors in the Intermittent Catheters Industry:
Increasing Prevalence of Urological Disorders
The global burden of urological disorders has expanded significantly in 2025, with a 35% increase in neurogenic bladder diagnoses linked to rising rates of spinal cord injuries and multiple sclerosis. Beyond chronic conditions, post-surgical urinary retention has become a major driver as hospitals standardize intermittent catheterization (IC) as the gold standard for post-operative care over indwelling options. This shift is supported by clinical data showing that IC reduces hospital-acquired infection rates by nearly 40%, making it the preferred protocol in over 70% of leading global urology centers.
Rising Adoption of Appropriate Reimbursement Rules
Improved reimbursement frameworks are a massive catalyst in 2025, specifically following the CMS announcement of new reimbursement codes effective January 2026. These updates allow for clearer differentiation and higher coverage for hydrophilic and closed-system catheters in the U.S. and Europe. In 2025, insurers are increasingly covering up to 200 single-use catheters per month, incentivizing patients to move away from risky "re-washing" practices. This policy shift has effectively reduced the out-of-pocket barrier for premium products, allowing manufacturers to scale the production of advanced, pre-lubricated kits for a wider patient demographic.
Growing Geriatric Population
The "Silver Tsunami" continues to reshape the market in 2025, as the global population over 65 seeks solutions that support independent living. Urinary incontinence now affects approximately 1 in 3 seniors, and intermittent catheters are increasingly prescribed as a "lifestyle tool" that permits "aging-in-place." Healthcare providers are prioritizing these devices for elderly patients to prevent the high morbidity associated with long-term indwelling catheters. The 2025 market sees a surge in demand for ergonomic, high-grip designs tailored for seniors with limited manual dexterity, ensuring that bladder management does not require permanent nursing intervention.
Key Trends in the Intermittent Catheters Market
Advancement of Patient-Centric Catheter Technologies
In 2025, technological innovation has moved toward Bio-active and Smart coatings. A significant trend is the rise of Antimicrobial-coated catheters using nitric oxide-releasing polymers or silver-ion technology, which have been shown to reduce infection risk by over 50%. Beyond infection control, "discreet design" has become a competitive necessity; manufacturers are now producing "pocket-sized" telescoping and foldable catheters that resemble cosmetic items. This focus on aesthetics and "no-touch" sleeve technology ensures that patients can manage their health with dignity and minimal risk of contamination, even in public settings.
Expansion of Home-Based Self-Catheterization and Digital Coaching
Home-care is the fastest-growing segment in 2025, expanding at a 7.5% CAGR. This growth is supported by a 47% rise in remote catheter education via telemedicine and AI-driven digital tutorials. Patients now use "Catheter Companion" apps that track usage frequency, hydration levels, and provide real-time troubleshooting via virtual consultations. This digital ecosystem has empowered over 60% of neurogenic bladder patients to transition successfully to self-catheterization within their own homes, significantly reducing the "readmission loop" for bladder-related complications and improving overall patient-reported quality of life.
Market Expansion Through Global Distribution and Sustainable Materials
The 2025 competitive landscape is defined by aggressive expansion into Emerging Economies, with India and China reporting 12-15% yearly increases in utilization. Strategic partnerships between Western giants (like Coloplast and BD) and regional distributors are localizing supply chains to make high-quality catheters affordable in low-income regions. Simultaneously, a new "Green Urology" trend is emerging; with billions of single-use units sold annually, manufacturers are introducing PVC-free and recyclable polymer catheters. This shift toward sustainability addresses tightening medical waste regulations while appealing to eco-conscious healthcare systems globally.
Leading Companies Operating in the Global Intermittent Catheters Industry:
- Adapta Medical, Inc.
- B. Braun SE
- Becton, Dickinson and Company
- Coloplast Corp
- Convatec Inc.
- Hollister Incorporated
- Medline Industries, LP
- Pennine Healthcare
- Teleflex Incorporated
- Wellspect HealthCare (Dentsply Sirona)
Intermittent Catheters Market Report Segmentation:
Breakup by Product:
- Uncoated Intermittent Catheter
- Coated Intermittent Catheter
- Antimicrobial
- Hydrophilic
- Others
Uncoated intermittent catheter dominates the market due to their continued success in enhancing patient comfort and infection control with cost-effective solutions.
Breakup by Indication:
- Urinary Incontinence
- Surgery (Major Surgery)
- Spinal Cord Injury
- Others
Urinary incontinence holds the largest share in the market as it affects over 423 million adults globally with growing awareness and diagnosis leading to increased adoption of intermittent catheters.
Breakup by Category:
- Male Length Catheter
- Kids Length Catheter
- Female Length Catheter
Female length catheter holds the maximum share in the market due to increasing prevalence of urinary disorders among women and catheters tailored to female anatomy for greater comfort.
Breakup by End User:
- Hospitals
- Medical Research Centers
- Ambulatory Surgical Centers
Hospitals hold the maximum share in the market as they handle higher volumes of patients requiring complex care with specialized medical staff and advanced facilities.
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
North America leads the market, accounting for the largest intermittent catheters market share driven by high prevalence of urological disorders, well-established healthcare infrastructure, and strong focus on home healthcare.
Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.
About Us:
IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sa...@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States:+1-201971-6302